Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
ArchivedNational Institutes of Health
Description
The purpose of this notice of funding opportunity (NOFO) is to support basic and applied research to define the mechanisms for establishing, developing and maintaining immunity to HIV in early life (from birth to less than 12 years of age), including the impact of prophylactic vaccination and broadly neutralizing HIV antibodies (bNAbs) to protect against acquisition of HIV infection.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH Grants Information<br/>grantsinfo@nih.gov
grantsinfo@nih.gov
- PostedJun 18, 2024
- ClosesOct 9, 2024
- Award ceiling$750,000
- CFDA93.855
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro